Open AccessLarge Subretinal Haemorrhage following Change from Intravitreal Bevacizumab to Ranibizumab
Author(s) -
Dimitrios Karagiannis,
Panagiotis Mitropoulos,
Ioannis D. Ladas
Publication year - 2009
Publication title -
ophthalmologica
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.639
H-Index - 60
eISSN - 1423-0267
pISSN - 0030-3755
DOI - 10.1159/000213644
Subject(s) - ranibizumab , medicine , bevacizumab , ophthalmology , macular degeneration , optometry , surgery , chemotherapy
To report 2 cases of large subretinal haemorrhage in 2 patients with age-related macular degeneration when the intravitreal injections were changed from bevacizumab (Avastin) to ranibizumab (Lucentis).
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom